FDA Inspection
Novartis d.o.o.Novartis d.o.o. – FDA Inspection, Feb 9, 2024
Record Details
This FDA Inspection record concerns Novartis d.o.o., with an inspection on February 9, 2024, issued by the Center for Drug Evaluation and Research.
- Company
- Novartis d.o.o.
- Inspection Date
- February 9, 2024
View Company Profile
ID · b15c18b8-94c8-4b0b-bfb1-8e8b16a99cbf
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1229017
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
FDA Citations
3- 21 CFR 211.170(b)Annual visual exams of drug products
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Novartis d.o.o.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 25, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novartis d.o.o.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.